BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30219448)

  • 41. Do Palliative Care Providers Use Complementary and Integrative Medicine? A Nationwide Survey.
    Goel AR; Henderson CR; Reid MC
    J Pain Symptom Manage; 2022 Apr; 63(4):599-609. PubMed ID: 34788656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care.
    Ben-Arye E; Schiff E; Steiner M; Keshet Y; Lavie O
    Int J Gynecol Cancer; 2012 Jan; 22(1):146-53. PubMed ID: 21912265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Giving voice to cancer patients: assessing non-specific effects of an integrative oncology therapeutic program via short patient narratives.
    Keshet Y; Schiff E; Samuels N; Ben-Arye E
    Psychooncology; 2015 Feb; 24(2):169-74. PubMed ID: 25043932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An exploratory typology of provider responses that encourage and discourage conversation about complementary and integrative medicine during routine oncology visits.
    Koenig CJ; Ho EY; Trupin L; Dohan D
    Patient Educ Couns; 2015 Jul; 98(7):857-63. PubMed ID: 25865412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. We and they in the house of healing: debate among Arab complementary medicine practitioners on an integrative versus alternative approach to supportive cancer care.
    Popper-Giveon A; Schiff E; Ben-Arye E
    Integr Cancer Ther; 2013 Nov; 12(6):488-95. PubMed ID: 23625026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eva Between Anxiety and Hope: Integrating Anthroposophic Music Therapy in Supportive Oncology Care.
    Ben-Arye E; Ben-Arye Y; Barak Y
    Health Psychol Res; 2015 Nov; 3(3):2199. PubMed ID: 26973967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Supportive cancer care: is integrative oncology the future?
    Theunissen I; Bagot JL
    Curr Opin Oncol; 2024 Jul; 36(4):248-252. PubMed ID: 38842016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do complementary and integrative medicine therapies reduce healthcare utilization among oncology patients? A systematic review of the literature and recommendations.
    Tillery R; McGrady ME
    Eur J Oncol Nurs; 2018 Oct; 36():1-8. PubMed ID: 30322499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coping in women with breast cancer in complementary and conventional care over 5 years measured by the mental adjustment to cancer scale.
    Carlsson M; Arman M; Backman M; Hamrin E
    J Altern Complement Med; 2005 Jun; 11(3):441-7. PubMed ID: 15992227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complementary and Integrative Medicine Use in Individuals Seeking Conventional Medical Oncology Care in Chile: Prevalence and Patient Characteristics.
    Lopez G; Salas CA; Cadiz F; Barriga C; Gonzalez P; Acevedo S; Raimilla P; Pincheira P; Naing A; Quiroga M
    J Glob Oncol; 2019 May; 5():1-6. PubMed ID: 31095454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of a patient-tailored integrative oncology intervention in the relief of pain in palliative and supportive cancer care.
    Ben-Arye E; Elly D; Samuels N; Gressel O; Shulman K; Schiff E; Lavie O; Minerbi A
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2361-2372. PubMed ID: 33433656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Integrative oncology: Report and place for a dedicated consultation in a comprehensive cancer center].
    Mastroianni B; Lochmann M; Girodet M; Blay JY; Christophe V; Chvetzoff G
    Bull Cancer; 2022 Dec; 109(12):1308-1314. PubMed ID: 36241460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complementary and Integrative Medicine in Head and Neck Cancer.
    Goodman JF; Wang MB
    Otolaryngol Clin North Am; 2022 Oct; 55(5):993-1006. PubMed ID: 36088155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Restoring Balance for People with Cancer Through Integrative Oncology.
    Fulop JA; Grimone A; Victorson D
    Prim Care; 2017 Jun; 44(2):323-335. PubMed ID: 28501232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast Cancer Integrative Oncology Care and Its Costs.
    Standish LJ; Dowd F; Sweet E; Dale L; Weaver M; Osborne B; Andersen MR
    Integr Cancer Ther; 2017 Mar; 16(1):85-95. PubMed ID: 27230757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.
    Krüerke D; Schenker M; Matter-Walstra K
    BMC Complement Med Ther; 2023 Nov; 23(1):395. PubMed ID: 37924102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complementary and Integrative Medicine to Reduce Adverse Effects of Anticancer Therapy.
    Rossi E; Noberasco C; Picchi M; Stefano MD; Rossi A; Nurra L; Ventura L
    J Altern Complement Med; 2018; 24(9-10):933-941. PubMed ID: 30247968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Integrative Oncology for Women with Breast Cancer].
    Kienle GS; Rist L
    Ther Umsch; 2021 Apr; 78(3):158-162. PubMed ID: 33775134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guidance for establishing an integrative oncology service in the Australian healthcare setting-a discussion paper.
    Grant SJ; Hunter J; Bensoussan A; Delaney GP
    Support Care Cancer; 2018 Feb; 26(2):471-481. PubMed ID: 28864857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrative oncology and complementary medicine cancer services in Australia: findings from a national cross-sectional survey.
    Smith CA; Hunter J; Delaney GP; Ussher JM; Templeman K; Grant S; Oyston E
    BMC Complement Altern Med; 2018 Oct; 18(1):289. PubMed ID: 30373631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.